Aggregator
KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging
How we call out the infuriating mistakes we spot in school science textbooks
Romeo and the robots
Trump blew up the global fight against AIDS. Can it recover?
Why we need to measure people’s well-being — lessons from a global survey
The end of AIDS is in sight: don’t abandon PEPFAR now
How to protect research data
Senators from both parties criticize Trump’s moves against NIH
Spending panel wants his policies reversed—but it may not have sufficient clout to succeed
‘Unethical’ AI research on Reddit under fire
Ethics experts raise concerns over consent, study design
NIH insiders: Trump is ‘dismantling and destroying everything’
After just 100 days, agency scientists say U.S. health institutes are demoralized and have lost essential staff and funding
How the Trump administration is dismantling science in the U.S.
The scientific workforce, biomedical research, and global health initiatives all face widespread, perhaps permanent damage
The 100 days that shook U.S. science
Trump’s chaotic push to remake federal research will have lasting consequences
New NIH office to reduce use of animals in research
Agency plans to promote alternative methods and address “bias” toward animal studies in grant review
Hunt for tree rings could yield Africa’s first drought atlas
Records could reveal how much humanity has altered Sahel rains
Trump’s team, often accused of spreading misinformation, slashes misinformation research
Hundreds of grants axed in a field where the United States was a global leader
Alzheimer's disease patient-derived high-molecular-weight tau impairs bursting in hippocampal neurons
Tau accumulation is closely related to cognitive symptoms in Alzheimer's disease (AD). However, the cellular drivers of tau-dependent decline of memory-based cognition remain elusive. Here, we employed in vivo Neuropixels and patch-clamp recordings in mouse models and demonstrate that tau, independent of β-amyloid, selectively debilitates complex-spike burst firing of CA1 hippocampal neurons, a fundamental cellular mechanism underpinning learning and memory. Impaired bursting was associated with...
CHAS infers cell type-specific signatures in bulk brain histone acetylation studies of neurological and psychiatric disorders
Epigenomic profiling of the brain has largely been done on bulk tissues, limiting our understanding of cell type-specific epigenetic changes in disease states. Here, we introduce cell type-specific histone acetylation score (CHAS), a computational tool for inferring cell type-specific signatures in bulk brain H3K27ac profiles. We applied CHAS to >300 H3K27ac chromatin immunoprecipitation sequencing samples from studies of Alzheimer's disease, Parkinson's disease, autism spectrum disorder,...
Accurate prediction of absolute prokaryotic abundance from DNA concentration
Quantification of the absolute microbial abundance in a human stool sample is crucial for a comprehensive understanding of the microbial ecosystem, but this information is lost upon metagenomic sequencing. While several methods exist to measure absolute microbial abundance, they are technically challenging and costly, presenting an opportunity for machine learning. Here, we observe a strong correlation between DNA concentration and the absolute number of 16S ribosomal RNA copies as measured by...
Lipid droplets: Emerging therapeutic targets for age-related metabolic diseases
Lipids metabolism is crucial in regulating aging and metabolic diseases. Lipid droplets (LDs) are dynamic, complex organelles responsible for the storage and release of neutral lipids, essential for maintaining lipid homeostasis and energy metabolism. Aging accelerates the accumulation of LDs, functional deterioration, and metabolic disorders, thereby inducing age-related metabolic diseases (ARMDs). This review examines published datasets on the association between LDs and ARMDs, focusing on the...
Facile generation of drug-like conformational antibodies specific for amyloid fibrils
Antibodies that recognize insoluble antigens, such as amyloid fibrils associated with neurodegenerative disorders, are important for research, diagnostic and therapeutic applications. However, these types of antibodies are difficult to generate, typically require animal immunization and also commonly require humanization in the case of therapeutic applications. Here we report a methodology for generating high-quality, fully human, conformation-specific antibodies against amyloid fibrils using a...